Ionic Pharmaceuticals

Ionic Pharmaceuticals is a private U.S. biotech and biomedical engineering company developing biomaterials, devices, and drug-delivery systems for wound care and oncology applications. The company is a spin-out of Boston University and applies polymer chemistry and biomedical engineering to create clinically oriented products. Its lead technology areas include a spray-on, dissolvable hydrogel dressing for burn wounds and an expansile nanoparticle platform designed to improve local delivery of chemotherapeutics to residual tumors after surgery. Ionic states that its nanoparticle approach uses a proprietary materials-based targeting strategy to improve tumor delivery efficiency versus conventional nanoparticle systems. The company appears to be operating at a preclinical stage and has been supported by NIH SBIR grants and private investment.